Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Invested Capital (2019 - 2025)

Historic Invested Capital for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$1.7 million.

  • Biodesix's Invested Capital fell 10618.16% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 10618.16%. This contributed to the annual value of $20.9 million for FY2024, which is 2103.49% down from last year.
  • As of Q3 2025, Biodesix's Invested Capital stood at -$1.7 million, which was down 10618.16% from $1.1 million recorded in Q2 2025.
  • Biodesix's Invested Capital's 5-year high stood at $42.1 million during Q2 2024, with a 5-year trough of -$1.7 million in Q3 2025.
  • Moreover, its 5-year median value for Invested Capital was $20.9 million (2024), whereas its average is $21.0 million.
  • Per our database at Business Quant, Biodesix's Invested Capital soared by 45626.32% in 2024 and then crashed by 10618.16% in 2025.
  • Over the past 5 years, Biodesix's Invested Capital (Quarter) stood at $37.5 million in 2021, then dropped by 17.45% to $30.9 million in 2022, then dropped by 14.57% to $26.4 million in 2023, then dropped by 21.03% to $20.9 million in 2024, then tumbled by 108.25% to -$1.7 million in 2025.
  • Its Invested Capital stands at -$1.7 million for Q3 2025, versus $1.1 million for Q2 2025 and $11.1 million for Q1 2025.